07:00 , Mar 26, 2012 |  BC Week In Review  |  Clinical News

Augment Rotator Cuff: Pilot trial data

BioMimetic reported that a single-blind, Canadian pilot trial in 30 patients showed that Augment Rotator Cuff plus standard suture repair met the primary safety endpoint with no device-related serious adverse events reported. The company also...
07:00 , Jun 13, 2011 |  BC Week In Review  |  Clinical News

Augment Rotator Cuff: Completed pilot trial enrollment

BioMimetic completed enrollment of 30 patients in a single-blind, Canadian pilot trial comparing Augment Rotator Cuff plus standard suture repair vs. standard suture repair alone. BioMimetic Therapeutics Inc. (NASDAQ:BMTI), Franklin, Tenn.   Product: Augment Rotator...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Clinical News

Augment Rotator Cuff: Pilot trial started

BioMimetic began a single-blind, Canadian pilot trial to compare Augment Rotator Cuff plus standard suture repair vs. standard suture repair alone in up to 30 patients. BioMimetic Therapeutics Inc. (NASDAQ:BMTI), Franklin, Tenn.   Product: Augment...